Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Application of genome editing technologies to the study and treatment of hematological disease.

Journal article

Pellagatti A. et al, (2016), Adv Biol Regul, 60, 122 - 134

Application of CRISPR/Cas9 genome editing to the study and treatment of disease.

Journal article

Pellagatti A. et al, (2015), Arch Toxicol, 89, 1023 - 1034

CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING

Conference paper

Valletta S. et al, (2015), HAEMATOLOGICA, 100, 169 - 169

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

Journal article

Spinelli R. et al, (2014), Molecular Genetics & Genomic Medicine, 2, 204 - 204

CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data

Journal article

Piazza R. et al, (2013), PLoS ONE, 8, e74825 - e74825

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Journal article

Piazza R. et al, (2013), LEUKEMIA RESEARCH, 37, S34 - S35

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Journal article

Piazza R. et al, (2013), Nat Genet, 45, 18 - 24

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Journal article

Piazza R. et al, (2013), Nature Genetics, 45, 18 - 24

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

Journal article

Piazza R. et al, (2012), Nucleic Acids Research, 40, e123 - e123